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Metalloproteinase generation by human glomerular epithelial cells. In
the present study cultured human glomerular epithelial cells (HGEC)
were used to examine the potential role for these cells in the turnover of
the glomerular basement membrane (GBM) through the secretion of
matrix metalloproteinases. The cells were shown by substrate gel electro-
phoresis to secrete gelatinase activity of molecular weights 72 kDa and 92
kDa. The gelatinolytic activity was inhibited by EDTA (10 mM), and by
both TIMP-I and TIMP-Il, but was not inhibited by PMSF (2.5 mM),
indicating that the enzymes belonged to the metalloproteinase family. The
identity of the enzymes was confirmed by the use of specific antisera to
gelatinase A and gelatinase B. In addition, reverse transcription poly-
merase chain reaction (RT PCR) amplification of HGEC mRNA using
specific primers to the two enzymes yielded single bands of amplified DNA
and served to verify the identity of the enzymes. In supplementary
experiments using both specific antiserum and PCR primers it was shown
that 1-IGEC express message and secrete both the specific metalloprotein-
ase inhibitors TIMP-I and TIMP-II. These results indicate that the
synthesis and secretion of degradative enzymes and their controlling
inhibitors by HGEC have the potential to be involved in the turnover of
the extracellular matrix.
The glomerular basement membrane forms the core of the
kidney filtration barrier and thus represents a highly specialized
form of extracellular matrix having a specific and well organised
macromolecular structure [1]. The constituent molecules include
a specialized membrane type IV collagen, laminin and the highly
charged basement membrane heparan sulphate proteoglycan
(perlecan) [2]. In the developing kidney it appears that the
components of the GBM are derived from both the endothelial
and visceral epithelial cells. In the adult kidney, however, the bulk
of the synthetic responsibility lies with the glomerular visceral
epithelial cells [3] which in a number of studies has been shown to
have the capacity to synthesize collagen type IV, laminin and
perlecan [4].
The integrity of the membrane depends on a continuous
process of remodeling and replacement of its constitutive parts,
and its catabolism is an event dependent on the coordinated
action of a number of enzymes. The basic lattice framework of the
barrier is provided by the type IV collagen, and its turnover is
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likely to be closely linked to the presence of specific matrix
metalloproteinases. This super-family of enzymes consists of a
number of subgroups each of which degrade at least one compo-
nent of the GBM [5]. They have a number of common character-
istics including activity at neutral pH, a divalent cation binding site
and the inhibition by specific tissue inhibitors of metalloprotein-
ases (TIMP). The subgroups have been identified by their sub-
strate specificity: collagenase, stromelysin, gelatinase (Type IV
collagenase). Two specific type IV collagenases have been char-
acterized and identified as gelatinase A and B. The former has a
molecular weight of 72 kDa and is mainly a product of connective
tissue cells [6]. Gelatinase B is of a higher molecular weight (92
kDa) and is produced mainly by PMN and macrophages [7].
Numerous studies have investigated the generation of neutral
metalloproteinases by mesangial cells [8] but few have addressed
the synthetic capacity of the epithelial cell. It has been reported
that the rat glomerular epithelial cell secretes matrix metallopro-
teinases, but the data are conflicting [9, 10]. Evidence for the
production of metalloproteinases by human epithelial cells is
sparse. In the present study we seek to characterize the synthesis
and secretion of gelatinases and their specific inhibitors by human
glomerular epithelial cells (HGEC).
Methods
Materials
All tissue cultural products were purchased from Sigma Chem-
ical Company (Dorset, UK) unless stated otherwise. All chemi-
cals, unless stated otherwise, were from Merck Ltd (Magna Park,
Lutterworth, Leicester, UK). The antibodies used for the charac-
terization of GEC were purchased from DAKO Ltd (High
Wycombe, Bucks, UK). FITC labeled antibodies were purchased
from ICN Biomedicals Ltd (High Wycombe, Bucks, UK). Sheep
antibodies raised against human 92 and 72 kDa gelatinases were
a gift from Dr. Gillian Murphy (Strangeways Research Laborato-
ries, Cambridge, UK). Antibodies to TIMP-I and the appropriate
pure standard were donated by Dr. P. Davies (Merck, Rahway,
NJ, USA). TIMP-Il antibody was provided by Dr. A. Docherty
(CeilTech Ltd, Slough, UK).
Primers based on published sequences of neutral proteinases
[11, 12] and of inhibitors [13, 14] were obtained from either
Oswell DNA Service, Edinburgh or synthesized by the Molecular
Biology Central Facility, University of Wales College of Medicine,
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Heath Park, Cardiff. The following specific primer sequences were
chosen to selectively amplify the coding sequences of interest:
Establishment of human glomerular epithelial cells (HGEC)
in culture
Human glomerular epithelial cells were cultured from speci-
mens of normal kidney obtained at nephrectomy. Glomeruli were
isolated from renal cortex by serial sieving and collected on a 125
,aM sieve [15]. Whole glomeruli were washed X3 with sterile PBS,
plated onto six-well 35 mm plastic plates (Falcon, Becton Dick-
inson & Co, Plymouth, UK) in RPMI 1640 (Flow Laboratories,
Irvine, Scotland, UK), buffered with NaHCO3 and supplemented
with 10% wt/vol FCS, 2 mrvi L-glutamine (ICN Biomedicals mc,
Costa Mesa, CA, USA), 20 nM HEPES buffer and 50 U/ml
penicillin, 50 g/ml streptomycin (Gibco/BRL Life Technologies
Ltd), 5 jg insulin, 5 J.Lg/ml transferrin, 5 ng/ml sodium selenite
and 0.4 pg/mI hydrocortisone and incubated at 37°C. Cell out-
growth with the morphological appearance of epithelial cells
usually occurred within two weeks. Glomeruli were then removed
by vigorous pipetting leaving intact adherent cells. When conflu-
ent, epithelial cells were passaged by incubation with an equal
volume of 0.25% wt/vol trypsin and 0.02% wt/vol EDTA, both
containing 0.1% wt/vol glucose. The detached cells were then
incubated with fresh culture medium containing 40% vol/vol FCS,
and centrifuged at 1000 g for 10 minutes. The cell pellet was
resuspended in fresh medium containing 10% vol/vol FCS and
grown in 25 cm2 uncoated plastic flasks (Falcon). Cells were
maintained in this way to passage 3.
Characterization of HGEC
Cells were characterized by morphology using phase contrast
microscopy and by immunostaining. HGEC were grown on plastic
chamber slides (Labtek, Permanox Gibco/BRL Life Technologies
Ltd). Confluent monolayers of cells were fixed in ice cold acetone/
methanol (1:1) at room temperature for five minutes and then
allowed to air dry. This method of fixation was found to necessary
in order to demonstrate the presence of cytokeratin. The follow-
ing antibodies were used: rabbit a human cytokeratin (Dako);
rabbit a human factor VIII (Dako); and rabbit a human vimentin
(ICN).
The second antibody used was FITC labeled goat anti-rabbit
(ICN). Negative controls consisted of replacing the primary antibody
with an irrelevant rabbit antibody or PBS.
Production of GEC conditioned medium
Glomerular epithelial cell monolayers (passages 1 to 3) were
washed )< 3 with sterile PBS to remove traces of FCS and the
culture was continued with serum free medium supplemented
with lactalbumin hydrolysate (LH) at a final concentration of
0,2% wt/vol. After 48 hours the medium was then replaced with
fresh LH containing medium and the incubation was continued
for a further three days, after which time the conditioned medium
(CM) was collected, centrifuged to remove any non-adherent cells
and stored at —20°C until assayed for enzymatic activity.
Enzyme assays
Substrate gel electrophoresis (zymography). Neutral proteinase
activity in CM from resting cells was visualized by SDS-PAGE
substrate gel electrophoresis. Soluble gelatin was prepared by
denaturing a 10 mg/ml (wt/vol) solution of purified rat tail
collagen [16] at 60°C for 30 minutes. Twenty microliters of each
sample were incubated with 10 d of sample buffer (0.5 M
Tris-HC1, pH 6.8, containing 40% wt/vol SDS) for two hours at
room temperature prior to electrophoresis. The non-reduced
samples were applied to a 7.5% (wt/vol) discontinuous polyacryl-
amide slab gels containing either 1 mg/mi gelatin or 1 mg/ml
casein. Electrophoresis was carried out at 4°C with 70 V constant
voltage for two to three hours. After electrophoresis the gels were
incubated at room temperature for one hour in 2.5% wt/vol Triton
X-100 and then overnight in 50 m'vi Tris-HCI, pH 7.6, containing
10 mM CaC12 and 0.05% (vol/vol) Brij 35. Gels were then stained
with 0.1% (wt/vol) Page blue 83 in 40% (vol/vol) methanol, 10%
(vol/vol) acetic acid for two to four hours followed by destaining
in 40% (vol/vol) methanol and 10% (vol/vol) acetic acid.
Functional gelatinase assay. One hundred microliters of CM
were incubated at 37°C for 18 hours with 50 jd gelatinase buffer
(0.4 M Tris-HC1, pH 8.0, containing 10 mM CaCl2) and 100 ,al
14C-labeled gelatin (1 mg/ml, i0 cpm/mi) [16], with or without 1
mM p-amino phenyl mercuric acetate (PAMA). Fifty microliters
of ice-cold 100% (wt/vol) trichloroacetic acid were then added
and the samples were incubated at 4°C for a further 30 minutes.
Insoluble protein was then pelieted by centrifugation at 11,000 X
g for 10 minutes. One hundred and fifty microliters of the
supernatant was mixed with 4 ml scintillation fluid Instagel
(Canberra Packard Ltd, Pangbourne, UK) and counted in a
Packard 1900 CA liquid scintillation counter for one minute. One
unit of gelatinase activity was defined as that amount of enzyme
which degraded 1 g of gelatin/hr, under the conditions used.
Characterization of gelatinase activity and inhibitor following
immunoprecipitation
One hundred microliters of cell CM was incubated with 40 .d of
appropriate specific antiserum at 4°C overnight. Fifty microliters
of a 20% wt/voi slurry of protein A linked to Sepharose beads
(Pharmacia, Milton Keynes, UK) was added and the suspension
incubated at 4°C for two hours with frequent mixing. Following
this the suspension was centrifuged at 1000 X g for five minutes
and the pellet washed x5 with ice-cold wash buffer (0.05 M Tris
HC1, pH 8.3, containing 0.45 M NaC1 and 0.5% vol/vol nonidet
P40). The pellet was then resuspended in 20 pA of SDS-PAGE
sample buffer as described above and allowed to stand for two
hours at room temperature. The particulate matter was sedi-
mented by centrifugation at 11000 X g for three minutes, the
supernatant carefully removed and applied to a gelatin substrate
gel for eiectrophoresis.
Immunoprecipitation was also used for the detection of the
tissue inhibitor of metalloproteinase II (TIMP-Il) in CM. One
hundred microliters of supernatant was incubated overnight at
5' 92 kDa gelatinase
3' 92 kDa gelatinase
5' 72 kDa gelatinase





5' AGA CCT GAG AAC CAA TCT CAC 3'
5' GOC ACT GAG GAA TGA TCT AA 3'
5' lTr TCI7 GGA ATC CAT GAT GO 3'
5' CTG GTG CAG CTC TCA TAT YT 3'
5' ATC CTG TFG TTG CTG TGG CTG 3'
5' GAC TGG AAG CCC TVF TCA GA 3'
5' GTT TUG CAA TGC AGA TGT AG 3'
5' ATG TGG AGA AAC TCC TGC IT 3'
1_
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Fig. 1. A. A phase contrast micrograph showing a confluent monolayer of
HGEC (x 100). B. Immunofluorescence microscopy of subconfiuent
HGEC staining positive for vimentin (x 500). C. Immunofluorescence
microscopy of subconfluent HGEC staining positive for cytokeratin (x
500).
Fig. 5. Indirect immunofluorescence demonstrating the production of gelatinase A and gelatinase B by the human glomerular epithelial cells, as shown by
positive staining in A and B respectively.
4°C with 10 pA anti-TIMP-Il antibody. Protein A Sepharose (50
pA) was added and the mixture incubated for a further 60 minutes
at 4°C with occasional mixing. The resulting slurry was centri-
fuged, the pellet washed x5 with ice-cold wash buffer and
resuspended in SDS-PAGE sample buffer containing mercapto-
ethanol (0.5% wt/vol). The slurry was boiled for five minutes and
centrifuged at 11000 X g for three minutes. The supernatant was
then resolved by SDS-PAGE on a 10% (wt!vol) discontinuous slab
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Fig. 2. HGEC culture medium (CM) applied to a gelatin substrate gel. Lane A shows bands of lysis at 92 kD and 68 ltD. Lane B shows the same band
of lysis following incubation of the gel with PMSF (2.5 mM). Lane C shows inhibition of the lysis with EDTA (20 mM).
FIg. 3. HGEC CM was subjected to
immunoprecipitation using specific antibodies to
gelatinase A and gelatinase B. Lane A control
CM. Lane B shows the immunoprecipitation of
sample applied to lane A by antibody to
gelatinase A. Lane C control CM. Lane D
immunoprecipitation of sample applied to lane
C by antibody to gelatinase B.
Fig. 4. PCR amplification of HGEC eDNA
using specific primers to gelatinase A (Lane A)
and gelatinase B (Lane B) showing DNA
products of the predicted length, confirming the















÷— 92 kD gelatinase
.e— 72 kD gelatinase
1686 Knowiden et al: Metalloproteinase generation by HGEC
Western blot analysis
CM was concentrated tenfold in a Centricon concentrator
(Amicon Ltd, Gloucester, UK), before being resolved by electro-
phoresis and transferred onto nitrocellulose filters for one hour at
100 V in a transblot apparatus (BioRad, Hemel Hempstead, UK),
according to the manufacturer's instructions. Non-specific binding
was blocked by incubating the filters in PBS, pH 7.4, containing
5% wt/vol skimmed milk for one hour at room temperature. The
filters were washed in PBS, incubated with the appropriate
antibody overnight at 4°C, washed in PBS and then incubated with
goat anti-rabbit IgG conjugated to alkaline phosphatase.
Semi-purification of gelatinase
The gelatinase activity was semi-purfied by passing the CM
down a gelation agarose affinity column (Sigma), equilibrated with
50 mM Tris, containing 0.5 M NaC1, 0.05% (wt/vol) Brij-35, 10 mM
EDTA, and then washed in the same buffer. The gelatinolytic
enzymes were eluted with 50 mrvi Tris, containing 1 M NaC1, 0.05%
(wt/vol) Brij-35, 10 mrvt EDTA and 5% DMSO (vol/vol). The
enzymes were finally dialyzed into 50 mivi Tris, 0.5 M NaCl, 0.05%
wt/vol Brij-35, 0.005 M CaC12.
Immunolocalization of gelatin A and B in HGEC
Immunolocalization of gelatinases in cultured HGEC was
carried out using a modification of the method described by
Hembry, Murphey and Reynolds for fibroblasts [181. Cultured
epithelial cells established on plastic chamber coverslips were
incubated with serum free medium for 16 hours, followed by three
hours in fresh serum-free medium containing 5 JLM monensin. The
monesin blocked the secretion of protein into the culture medium
to ensure intracellular accumulation of products. The cells were
then fixed for 10 minutes in 4% wt/vol paraformaldehyde and
permeabilized with 0.1% (vol/vol) Triton X-100 for 10 minutes at
room temperature. Fixed cell monolayers were incubated for 45
minutes with (½5o) dilution of whole immune IgG antiserum to
either gelatinase A or B followed by incubation for a further 45
minutes with a second antibody FITC labeled rabbit f(ab)2
anti-sheep IgG (Europath Ltd, Bude, UK) at a dilution of (½so).
Cells were examined by fluorescence microscopy and photo-
graphed on Ektar film rated at 1000 ASA by epi illumination.
RNA isolation, reverse transcription and PCR amplification
HGEC were grown to confluence, growth arrested as described
above and incubated in medium containing 0.2% LH for six hours
at 37°C. Total cellular RNA was extracted with RNA zol B
(Biogenesis Ltd, Yeomans Way, Bournemouth, UK) following the
manufacturer's directions. Total RNA was reverse transcribed
into cDNA with MMLVTM reverse transcriptase (Gibco/BRL
Life Technologies Ltd) using the random hexamers method [19].
The reaction mixture contained 1 tl random hexamers (100 jiM;
Pharmacia Biosystems Ltd, Milton Keynes, UK), 5 jil dNTPs (2.5
mM; Gibco/BRL Life Technologies), 2 l PCR buffer (100 mM
Tris-HC1, 500 mivi KC1, 15 mrvi MgC12 and 0.01% wt/vol gelatin),
2 jil DTT (0.1 M; Gibco/BRL Life Technologies), 1 jil RNAase
inhibitor (Promega, Southampton, UK), 1 jil MMLVTM RT 200
units (Gibco/BRL Life Technologies) and 1 jig of total RNA to a
final volume of 20 jil. PCR amplification was performed in a total
volume of 50 jil (2 jil of RT product and 48 jil of mastermix
solution comprised 36.25 jil H20, 1.25 jil 5'-primer (20 jiM), 1.25
il 3'-primer (20 jiM), 4 p1 dNTPs (2.5 mM), 5 p1 lOx PCR buffer
and 0.25 p1 Taq polymerase (2.5 U, Amphlitaq©, ILS Ltd,
London, UK), using a Perkin Elmer Themocycler (PEC; ILS Ltd).
The PCR protocol was as follows: first cycle 94°C for three
minutes, 55°C for one minute, 72°C for one minute. The remain-
ing 34 cycles are: 94°C for 40 seconds, 55°C for one minute, 72°C
for one minute. The final cycle was 94°C for one minute and 60°C
for 10 minutes. One fifth of the PCR reaction product was mixed
with loading buffer (40% wt/vol sucrose) and separated by flat bed
electrophoresis in a gel composed of 2% wt/vol Nuseive GTG
agarose (Flowgen Instruments Ltd, Sittingbourne, UK) and 1%
wt/vol agarose (BRL) containing ethidium bromide (0.5 jiglml).
A standard lane comprised 1 p1 of 123 bp DNA ladder from




Confluent first to third passage human glomerular epithelial
cells when visualized by phase contrast microscopy were round in
shape, of uniform size and tightly apposed to each other, giving an
overall cobblestone appearance (Fig. 1A). By immunofluores-
cence the cells were negative for Factor VIII (endothelial cell
marker) and positive for both vimentin (Fig. 1B) and cytokeratin
(Fig. 1C). They were negative for intracellular actin fibrils which
were shown to be present in mesangial cells (data not shown).
Control cultures stained with normal rabbit serum followed by
FITC labeled goat anti-rabbit showed no fluorescence.
Secretion of gelatinase-degrading activity by human HGEC
Human visceral epithelial cells were examined for their ability
to secrete gelatin degrading proteases. Supernatants from resting
cells were separated on an SDS-PAGE gelatin substrate gel under
non-reducing conditions. A major zone of lysis of gelatinolytic
activity was seen as a doublet at 67 kDa with a minor zone at 92
kDa (Fig. 2, lane A). The appearance of these bands of lysis were
completely inhibited by the addition of EDTA (20 mM; Fig. 2, lane
C). In contrast the serine proteinases inhibitor (PMSF; 2.5 mM)
failed to inhibit the gelatinolytic effect (Fig. 2, lane B).
In addition, both of the specific inhibitors for metalloprotein-
ases TIMP-I and TIMP-Il were able to inhibit approximately 95%
of the gelatinolytic activity of the semi-purified gelatinases when
added to a functional assay for the degradation of '4C-gelatinase.
The presence of stromelysin and matrilysin in the supernatant was
excluded by the absence of lytic zones when the culture medium
was applied to a casein substrate gel.
Analysis of gelatinolytic activity
Supernatants from cultured GEC were incubated separately
with specific antibodies to gelatinase A and to gelatinase B. The
resulting precipitates were subjected to SDS-PAGE electrophore-
sis in a gelatin substrate gel (Fig. 3). With antibodies to gelatinase
A twin bands of lysis were observed demonstrating the presence of
both active (66 kDa) and latent (68 kDa) forms of the enzyme
(lane B). An additional band (molecular wt 116 kDa) was also
observed. Similar experiments were carried out using antibodies
to gelatinase B and showed a clear zone of lysis at 92 kDa and in
addition some lytic activity was seen at approximately 110 kDa
(lane D).
TIMP I GEC CM TIMP II GEC CM
STD STD
Fig. 6. A Western blot of concentrated HGEC CM demonstrating the presence of both TIMP-1 at approximately 28 kDa and TIMP-JI at approximately 21
kDa.
To confirm the identity of the gelatinases generated by GEC,
RNAwas extracted from resting cells after six hours of incubation
in fresh medium and reverse transcribed. PCR amplification was
then carried out on the cDNA using specific primers designed for
each of the gelatinases. Single bands of amplified DNA of 620 bp
for gelatinase A and 1100 bp for gelatinase B were obtained as
predicted by the chosen primers (Fig. 4).
Immunological localization of intracellular gelatinases
Following indirect immunofluorescence, HGEC cultured in the
presence of monensin were demonstrated to contain gelatinases A
and B (Fig. 5). Positive staining was uniform throughout all cells
in the culture. No staining could be seen when cells were
incubated with normal sheep serum (as a primary antibody) or
PBS alone.
Generation and secretion of specific metalloproteinase inhibitors
Supernatants from cultured cells were examined for the pres-
ence of specific metalloproteinase inhibitors. Conditioned me-
dium from GEC was concentrated tenfold and applied to 15%
SDS PAGE, separated and transferred onto nitrocellulose. Spe-
cific antibodies against either TIMP-I or TIMP-Il were used to
demonstrate the presence of the inhibitors (Fig. 6). The antibody
to TIMP-I produced a hand at approximately 29 kDa, correspond-
ing to the purified TIMP-I, and the antibody to TIMP-Il showed
a band with an apparent molecular weight of 23 kDa, similar to
the purified TIMP-Il.
RNA extracted from the cultured GEC was reverse transcribed,
followed by PCR amplification using specific primers designed for
TIMP-I or TIMP-Il. In both cases single bands of cDNA were
observed of predicted sizes for each inhibitor (520 bp for TIMP-I
and 540 bp for TIMP-Il) based on the selective primers used (Fig.
7).
Discussion
In this study we describe the detection and characterization of
gelatin degrading activity in the conditioned medium of resting
cultured human glomerular epithelial cells. Substrate gel analysis
of this conditioned medium indicated that the major gelatin
degrading proteinase was a doublet of apparent niass 66 to 68
kDa. In addition a lesser, but consistent band was observed at 92
kDa. The relative amounts of active and latent forms of the
enzymes, and the regulation of their activation was not studied in
this work; however, both enzymes were secreted, mostly in the
latent form. The degradation of gelatin by both enzymes was
inhibited by EDTA as well as TIMP-I and -II. This data strongly
suggest that both proteins belong to the zinc metalloproteinase
family of enzymes. Further analysis identified the two proteinases
(i) by use of specific antibodies to gelatinase A (72 kDa type IV
coflagenase) and to gelatinase B (92 kDa type IV collagenase) and
(ii) by PCR amplification of eDNA derived from the RNA of
unstimulated cells. The high molecular weight band (— 116 kD)
which is occasionally seen in zymograms of HGEC CM and which
is present in Figure 3 has not been studied in this work. However,
it is likely that this zone of lysis represents the complex of
gelatinase A which has been previously described by Howard,
Bullen and Banda [20].
The glomerulus consists of three types of cells: endothelial,
epithelial and mesangial. While little is known about the ability of
glomerular endothelial cells to secrete matrix metalloproteinase,
it is well documented that both rat and human glomerular
mesangial cells express and secrete gelatinase A [21, 22]. Less well




















Fig. 7. PCR amplification of HGEC cDNA using specific primers to
TIMP-I (Lane A) and TIMP-Il (Lane B) showing DNA products of the
predicted length, confirming the ability of HGEC to synthesize mRNA for
both inhibitors.
documented is the fact that gelatinase B is secreted when these
cells are stimulated with cytokines or phorbol ester [23]. The cells
used in the present study were homogenous and exhibited no
morphological features of mesangial cells. Their identity as gb-
merular epithelial cells was based on a cobblestone appearance,
growth as monolayers, the presence of vimentin and cytokeratin
and the absence of factor VIII and actin/myosin fibrils which act
as specific makers for the identification of endothelial and me-
sangial cells, respectively. We found that the fixation of the cells
with ice cold acetone/methanol (1:1) for five minutes followed by
air drying was necessary in order to demonstrate the presence of
cytokeratin in these cells. Other methods of fixation such as
paraformaldehyde failed to demonstrate the presence of this
antigen. Cytokeratin has previously been used as a marker for
glomerular epithelial cells in culture [10, 24]. There is, however,
work published from studies using rat cells [25] that demonstrates
that although these cells do express the marker cytokeratin in vitro
it is not present on podocytes in vivo, suggesting that either the
cells change their pheontype on culture, or perhaps that the cells
under investigation, are in fact either parietal epithelial cells or
are derived from tubular epithelium. The absence of contaminat-
ing tubules and the visualization of the outgrowth of these cells
from dc-capsulated glomeruli make these possibilities unlikely in
this study. Thus it appears that when stained under the appropri-
ate conditions glomerular podocytes demonstrate the presence of
cytokeratin in culture. Our studies demonstrate that human
glomerular epithelial cells can produce at least two matrix degrad-
ing proteinases. To date we have also demonstrated in preliminary
experiments that these cells express and synthesize interstitial
collagenase (data not shown), but as yet have failed to demon-
strate the synthesis of stromelysin or matrilysin.
Prior to our study members of the metalloproteinase family
have not been characterized or detailed in human glomerular
epithelial cells. Indeed there is only one previous report of
metalloproteinase synthesis by human epithelial cells [26]. Rat
glomerular epithelial cells, however, have been documented to
secrete neutral proteinases. Watanabe, Kinoshita and Nakagawa
[9] report that these cells secrete two major species of gelatin
degrading metalloproteinase with molecular masses of 98 kDa
and 68 kDa, and with minor ones at 75 kDa and 61 kDa. All these
proteinases were inhibited by phenanthroline but not PMSF,
clearly indicating that they were metalloproteinases. In sharp
contrast to these results Johnson et al [10] reported that rat
glomerular epithelial cell secrete a proteinase with a molecular
mass of 150 kDa (major species) as determined by gelatin
substrate gel zymography. This enzyme was active at neutral pH
and inhibitable with EDTA, but surprisingly not by TIMP-Il.
Since Northern analysis for the mRNA failed to detect either the
68 kDa gelatinase A or the 92 kDa gelatinase B, these authors
concluded that their enzyme was unrelated to the matrix metal-
loproteinase super-family of collagenases. In addition, there has
been recent preliminary data [27] claiming that GEC from an
unspecified source secrete a prominent 98 kD band of gelatino-
lytic activity that is due to a novel metalloproteinase distinct from
gelatinase B (MMP9). It will be interesting to see whether these
enzymes are new members of the metalloproteinase family. A
similar but not identical gelatin-degrading neutral proteinase (116
kDa) to that reported above has been isolated from freshly
isolated whole rat glomeruli cultured in serum-free medium [281.
The difference between our data with that reported from rat
glomerular epithelial cells cannot at present be explained other
than it represents a species difference. Species differences be-
tween rat and human mesangial cells grown in culture is well
documented [29, 30]. The detection of a 72 kDa gelatinase/type
IV collagenase with our in vitro cell system also raises the question
as to the possible function for this enzyme in the normal glomer-
ulus. The glomerular epithelial cell is involved in the synthesis and
turnover of the glomerular basement membrane. Therefore one
possible function of the epithelial derived gelatinase is its involve-
ment in the re-modelling of the glomerular basement membrane.
Turnover of extracellular matrix such as the glomerular basement
membrane is viewed as a two step process [8, 311. In the first phase
the matrix is subjected to digestion by secreted neutral proteinases
such as gelatinase A, collagenase or stromelysin, and in the second
the products released are endocytosed and are totally degraded
within the lysosomal system by the concerted action of acid
cathepsins. Our finding that glomerular epithelial cells also se-
crete TIMP-I and TIMP-II indicate that any such action of the
gelatinase on the components of the glomerular basement mem-
brane may be tightly regulated, and as such would represent a
critical molecule in a controlled turnover of the glomerular filter.
Reprint requests to John D. Williams, M.D., Institute of Nephrology,
University of Wales College of Medicine, Cardiff Royal infi rma?y, Cardiff CF2
1SZ, Wales, United Kingdom.
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